Imfinzi found to improve survival in small cell lung cancer

Imfinzi found to improve survival in small cell lung cancer - PharmaTimes

- June 27, 2019

Imfinzi found to improve survival in small cell lung cancer PharmaTimes

AstraZeneca has announced that its monoclonal antibody, Imfinzi (durvalumab), was found to improve overall survival at interim analysis in the Phase III ...

Search This Blog

Lung Cancer

Imfinzi found to improve survival in small cell lung cancer - PharmaTimes

Comments

Post a Comment

Popular posts from this blog

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago

Not An Ordinary Cough: Lung Cancer Symptoms That You Might Neglect - International Business Times

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago